Advertisement

Topics

VIDEO: Dimerix CEO On Surprising Phase II Data Discovery

00:23 EST 27 Dec 2017 | SCRIP

Dimerix is changing its R&D strategy for kidney disease drug based on surprising findings from a Phase II study.

      

Related Stories

 

Original Article: VIDEO: Dimerix CEO On Surprising Phase II Data Discovery

NEXT ARTICLE

More From BioPortfolio on "VIDEO: Dimerix CEO On Surprising Phase II Data Discovery"

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...